Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis.
Felix G GassertSebastian ZiegelmayerJohanna LuitjensFlorian T GassertFabian TollensJohann RinkMarcus R MakowskiJohannes RübenthalerMatthias F FroelichPublished in: European radiology (2021)
• Additional MRI of the liver for initial staging of pancreatic cancer results in lower total costs and higher effectiveness. • The economic model showed high robustness for varying input parameters.